Penn Researchers Uncover Novel Immune Therapy for Pancreatic Cancer

PHILADELPHIA - Researchers at the University of Pennsylvania's Abramson Cancer Center have discovered a novel way of treating pancreatic cancer by activating the immune system to destroy the cancer's scaffolding. The strategy was tested in a small cohort of patients with advanced pancreatic cancer, several of whose tumors shrank substantially. The team believes their findings - and the novel way in which they uncovered them -- could lead to quicker, less expensive cancer drug development.
more

More AFCRI news

Stay Connected to AFCRI

AFCRI NEWS

 

The Abramson Family Cancer Research Institute at the University of Pennsylvania Cancer Center
AFCRI on twitter
twitter
AFCRI on YouTube
Youtube


facebook



EVENTS

Abramson Family Cancer Research Institute Events

 

Learn more

RESEARCH AREAS AND STUDY PROGRAMS

 

Share |

VIDEOS FEATURING OUR RESEARCH TEAM

 



Genetically Modified "Serial Killer" T Cells Obliterate Tumors in Patients with Chronic Lymphocytic Leukemia, Penn Researchers Report

Penn Researchers Uncover Novel Immune Therapy for Pancreatic Cancer

Drug Stimulates Immune System to Attack "Scaffolding" Around Tumors



Personalized Medicine - Your Life is Worth Penn Medicine

Promotional video featuring the Abramson Cancer Center